- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
A critical financial and capability analysis of the producing Nanotechnology industry in China
nABACUS® Pty Ltd today announced that the
company released the first industry report for 2006 in its BlueBook® Series of industrial
“The China Industrial Nanotechnology Report 2006 is the culmination of twelve months
analysis of companies involved in producing commercially available original Nanotechnology
and Nanotechnology enhanced products in China,” said Yingqui He, Chief Analyst China of
From the over 600 Nanotechnology firms investigated a selection of the 80 most active and to be watched firms made it into the BlueBook® report. Companies were analyzed for their degree of engagement in development or production of Nanotechnologies as well as capacity to produce at industrial scale. “We were very impressed about the quality of companies we came across. Over 90% of companies covered in this report are ISO certified,” said Ms He.
What is included in this report?
The report only covers companies which reside in mainland China. Only companies with demonstrated industrial scale activities of producing original Nanotechnology products or Nanotechnology enhanced products have been included in this report. A company had to have at least RMB 10 million of either annual turnover or registered capital to be considered for inclusion in this report, which made it possible to also highlight uniquely positioned, fast growing companies that may be of interest to foreign companies for licensing or investment opportunities. A large fraction of companies included in this report (50%) have reported an annual turnover of over RMB 100 million.
What is not included in this report?
The number of Nanotechnology companies is growing on an almost daily basis, however, only a fraction of the widely published figure of Nanotechnology companies in China has some meaningful production output (if at all), or financial turnover or dedicated full time employees. In the selection of companies we excluded academic organizations acting as companies and the many very small companies affiliated to academic organizations which are frequently run on a part time basis by academics or academicians. Also not included are companies where we were unable to verify claims of active Nanotechnology development, Nanotechnology products or Nanotechnology usage in production. The report does not include companies with Nanotechnology developing and production sites in Taiwan and Hong Kong.
About The BlueBook® Series:
The BlueBook® Series analyses Nanotechnology companies and industry sectors in Asia and Australasia. The information provided in this Series comprises a collection of financial and technical data and background information relevant to the investment community; companies seeking to extend their market and to assess market risks and opportunities; and companies seeking opportunities to partner, joint venture or to become a licensor or licensee of a particular technology. The BlueBook® Series provides relevant information for industry bodies and policy makers who seek to assess industry sector trends and sector position within the international market.
nABACUS® is a Nanotechnology consulting and analysis company providing a well-defined range of expert services to a variety of industries and governments. nABACUS® core business is in the brokerage of Nanotechnology at large. Nanotechnology brokerage brings developers and manufacturers of Nanotechnology together with trading and distribution companies. nABACUS® analyses Nanotechnology and companies for their product, technology, trading and investment readiness. nABACUS® analyses Nanotechnology industry sectors for custom reports and as part of its Nanotechnology industry BlueBook® Series.
For more information, please click here.Media Contact:
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Small but heading for the big time: Nanobiotix half year results for the six months ended 30 June 2015, in line with expectations: Major clinical achievements and corporate developments August 28th, 2015
A new technique to make drugs more soluble August 28th, 2015
Nanocatalysts improve processes for the petrochemical industry August 28th, 2015
Nanolab Technologies LEAPS Forward with High-Performance Analysis Services to the World: Nanolab Orders Advanced Local Electrode Atom Probe (LEAP®) Microscope from CAMECA Unit of AMETEK Materials Analysis Division August 27th, 2015